Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

Englund, 1981, Oral versus vaginal absorption in oestradiol in postmenopausal women, 86, 297

Hargrove, 1989, Absorption of oral progesterone is influenced by vehicle and particle size, Am. J. Obstet. Gynecol., 161, 948, 10.1016/0002-9378(89)90759-X

Higuchi, 1985, 301

Kondo, 1994, Improved oral absorption of enteric coprecipitates of a poorly soluble drug, J. Pharm. Sci., 83, 566, 10.1002/jps.2600830425

Kondo, 1993, Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals, Biol. Pharm. Bull., 16, 796, 10.1248/bpb.16.796

Kondo, 1993, Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region, Chem. Pharm. Bull., 41, 737, 10.1248/cpb.41.737

Nimmerfall, 1980, Dependence of area under the curve on proquazone particle size and in vitro dissolution rate, J. Pharm. Sci., 69, 605, 10.1002/jps.2600690538

Nygard, 1987, Analysis of danazol in serum using high-performance liquid chromatography, J. Chromatogr., 415, 438, 10.1016/S0378-4347(00)83240-5

Schott, 1985, 271

Shastri, 1980, Relationship among particle size distribution, dissolution profile, plasma values and anthelmintic efficacy of oxfendazole, Am. J. Vet. Res., 41, 2095

Watari, 1983, Nonlinear assessment of nitrofurantoin bioavailability in rabbits, J. Pharmacokinet. Biopharm., 11, 529, 10.1007/BF01062210